Head-to-head · computed 2026-08-11
Henry Meds vs TMates
Henry Meds: Henry's all-inclusive semaglutide runs $297/month ($247 on 6-month and $197 on 12-month prepaid bundles) and tirzepatide $349/month; a separately marketed 'as low as $149' microdose floor is a different program. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| Henry Meds | TMates | |
|---|---|---|
| All-in maintenance | $179/mo | $297/mo |
| Best plan rate | $179/mo | $167/mo |
| 12-month total | $2,148 | $2,004 |
| Status | Reported · 2026-07-14 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, Henry Meds's $179 a month undercuts TMates's $297 by $118 a month at the 10 mg/wk maintenance basis — $1,416 across a year. Henry Meds's figure is reported (captured 2026-07-14) and TMates's is reported (captured 2026-07-14); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Henry Meds's tirzepatide ladder runs $179 a month billed monthly. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats Henry Meds's $2,148 by $144 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Henry Meds | TMates | |
|---|---|---|
| All-in maintenance | $179/mo | $249/mo |
| Best plan rate | $197/mo | $158/mo |
| 12-month total | $2,364 | $1,896 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $249 a month undercuts Henry Meds's $297 by $48 a month at the 2.4 mg/wk maintenance basis — $576 across a year. TMates's figure is reported (captured 2026-07-14) and Henry Meds's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Henry Meds's semaglutide ladder runs $297 a month billed monthly, $247 a month on a six-month plan, and $197 a month on a twelve-month plan. TMates's runs $249 a month billed monthly, and $158 a month on a twelve-month plan. On the twelve-month basis TMates's $1,896 beats Henry Meds's $2,364 by $468 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, Henry Meds is dose-flat — the price survives titration — while TMates's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses. On exit terms, TMates's structure avoids prepaid lock-in while Henry Meds's better rates ride prepaid terms — cheaper per month, costlier to leave early; read the refund language before choosing the discount.
Structure, side by side
Henry Meds
- MembershipNone
- Dose policyFlat — $179/mo tirzepatide and $179/mo semaglutide at every dose, per reported sources
- CommitmentMonth-to-month; 6/12-month bundles prepaid
- CancellationCancel before renewal; bundle refunds limited
- PharmacyPartner pharmacies
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
Henry Meds: Two independent 2026 captures (RangeYourself Jul 2026, RxPepsDirect May 2026) consistently show $179/mo flat for tirzepatide, replacing our Aug-5 $349 provider-stated figure. Henry's pharmacy partner is not publicly named. Semaglutide plan tiers ($179–$297) remain from our prior captures pending full reconciliation with the updated tirz figure.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is Henry Meds or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Henry Meds vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Henry Meds and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $2,148 at Henry Meds and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Henry Meds · TMates. Official sites: Henry Meds ↗ · TMates ↗. Nothing here is medical advice.